<0> CovidienLynn Phillips, 314-654-3263Manager, Media RelationsPharmaceuticalsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor RelationsorStephen Littlejohn ...
CONSHOHOCKEN, PA and VANCOUVER, BC, March 23 /PRNewswire/ - Neuromed Pharmaceuticals, Inc. today announced positive results of a pivotal phase 3 clinical trial of its lead investigational drug, Exalgo ...
WASHINGTON - Shares of CombinatoRx Inc. plunged 17 percent Tuesday after FDA drug reviewers said Exalgo, a once-daily, extended-release formulation of hydromorphone, may pose a relatively higher risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results